Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001437749-25-036357
Filing Date
2025-11-25
Accepted
2025-11-25 17:26:44
Documents
15
Effectiveness Date
2025-11-25
Reference 429
333-280388

Document Format Files

Seq Description Document Type Size
1 FORM S-8 nby20251125_s8.htm S-8 97623
2 EXHIBIT 5.1 ex_893288.htm EX-5.1 8342
3 EXHIBIT 23.1 ex_893289.htm EX-23.1 2293
4 EXHIBIT FILING FEES ex_893290.htm   iXBRL EX-FILING FEES 16345
5 rglogo.jpg GRAPHIC 3444
  Complete submission text file 0001437749-25-036357.txt   249677

Data Files

Seq Description Document Type Size
17 EXTRACTED XBRL INSTANCE DOCUMENT ex_893290_htm.xml XML 4942
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

EIN.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-291792 | Film No.: 251522739
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)